News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|July 26, 2022

Fezolinetant making waves for VMS

Author(s)Morgan Ebert

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

ByJoshua Fitch, Senior Editor

June 1st 2026

New parental support metrics give US an "F" for paid leave and childcare policies | Image credit: Stock.Adobe.com

New parental support metrics give US an "F" for paid leave and childcare policies

ByJoshua Fitch, Senior Editor

May 28th 2026

Genevieve Neal-Perry, MD, PhD, explains real-world performance of fezolinetant

Genevieve Neal-Perry, MD, PhD, explains real-world performance of fezolinetant

ByGenevieve Neal-Perry, MD, PhD

May 27th 2026

David Shalowitz, MD, MSHP, explains new dual approach for postmenopausal bleeding

David Shalowitz, MD, MSHP, explains new dual approach for postmenopausal bleeding

ByDavid I. Shalowitz, MD, MSHP

May 26th 2026

David Shalowitz, MD, MSHP, explains takeaways from ACOG's guidance on postmenopausal bleeding

David Shalowitz, MD, MSHP, explains takeaways from ACOG's guidance on postmenopausal bleeding

ByDavid I. Shalowitz, MD, MSHP

May 19th 2026

Latest CME

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Washington

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Washington

Alison K. Conlin, MD; Neil M. Iyengar, MD

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Yan Ji, MD; Neil M. Iyengar, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

Individualized TRT demonstrates broad symptom improvements beyond sexual function